Treatment of a patient with severe haemophilia A presenting with left extra pleural haematoma and diagnosed with inhibitors – case report

1 Soucie JM, Evatt B, Jackson D; Hemophilia Surveillance Systems Project Investigators. Occurrence of hemophilia in the United States. Am J Hematol 1998;59(4):288–94. doi: 10.1002/(sici)1096-8652(199812)59:4<288::aidajh4>3.0.co;2-i. SoucieJM EvattB JacksonD Hemophilia Surveillance Systems Project Investigators Occurrence of hemophilia in the United States Am J Hematol 1998 59 4 288 94 10.1002/(sici)1096-8652(199812)59:4<288::aidajh4>3.0.co;2-i Open DOISearch in Google Scholar

2 Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males. A meta-analytic approach using national registries. Ann Intern Med 2019; 171(8): 540–546. doi: 10.7326/M19-1208. IorioA StonebrakerJS ChambostH Establishing the prevalence and prevalence at birth of hemophilia in males. A meta-analytic approach using national registries Ann Intern Med 2019 171 8 540 546 10.7326/M19-1208 Open DOISearch in Google Scholar

3 Morais SA, du Preez HE, Akhtar MR, Cross S, Isenberg DA. Musculoskeletal complications of haematological disease. Rheumatology (Oxford) 2016; 55(6): 968–81. doi: 10.1093/rheumatology/kev360. MoraisSA du PreezHE AkhtarMR CrossS IsenbergDA Musculoskeletal complications of haematological disease Rheumatology (Oxford) 2016 55 6 968 81 10.1093/rheumatology/kev360 Open DOISearch in Google Scholar

4 Dutta A, Dutta TS, Dey P. Clinical profile of haemophilia patients of upper Assam—a hospital-based study. J Evol Med Dent Sci 2017;6(37): 2990–4. DuttaA DuttaTS DeyP Clinical profile of haemophilia patients of upper Assam—a hospital-based study J Evol Med Dent Sci 2017 6 37 2990 4 10.14260/Jemds/2017/645 Search in Google Scholar

5 Gavrel M, Rafowicz A, D’Oiron R, Franchi-Abella S, Lambert T, Adamsbaum C. Imaging features of atypical bleeds in young patients with hemophilia. Diagn Interv Imaging 2019; 100(3): 135–45. doi: 10.1016/j.diii.2018.11.010. GavrelM RafowiczA D’OironR Franchi-AbellaS LambertT AdamsbaumC Imaging features of atypical bleeds in young patients with hemophilia Diagn Interv Imaging 2019 100 3 135 45 10.1016/j.diii.2018.11.010 Open DOISearch in Google Scholar

6 Eshghi P, Khafafpour Z, Malek F, Habibpanah B. Massive spontaneous hemothorax in a child with hemophilia. Iran J Blood Cancer 2019; 11(4): 148–9. EshghiP KhafafpourZ MalekF HabibpanahB Massive spontaneous hemothorax in a child with hemophilia Iran J Blood Cancer 2019 11 4 148 9 Search in Google Scholar

7 Carcao M, Goudemand J. Inhibitors in Hemophilia: A Primer. Fifth edition. 2018. Montréal: World Federation of Hemophilia. Available at https://www1.wfh.org/publication/files/pdf-1122.pdf (accessed 13 April 2022). CarcaoM GoudemandJ Inhibitors in Hemophilia: A Primer Fifth edition 2018 Montréal World Federation of Hemophilia Available at https://www1.wfh.org/publication/files/pdf-1122.pdf (accessed 13 April 2022). Search in Google Scholar

8 Oldenburg J, Mahlangu J, Kim B, et al. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med 2017; 377(9): 809–818. doi: 10.1056/NEJMoa1703068. OldenburgJ MahlanguJ KimB Emicizumab prophylaxis in hemophilia A with inhibitors N Engl J Med 2017 377 9 809 818 10.1056/NEJMoa1703068 Open DOISearch in Google Scholar

9 Young G, Callaghan M, Dunn A, Kruse-Jarres R, Pipe S. Emicizumab for hemophilia A with factor VIII inhibitors. Expert Rev Hematol 2018; 11(11): 835–846. doi: 10.1080/17474086.2018.1531701. YoungG CallaghanM DunnA Kruse-JarresR PipeS Emicizumab for hemophilia A with factor VIII inhibitors Expert Rev Hematol 2018 11 11 835 846 10.1080/17474086.2018.1531701 Open DOISearch in Google Scholar

10 Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9(4): 418–35. doi: 10.1046/j.1365-2516.2003.00780.x. WightJ PaisleyS The epidemiology of inhibitors in haemophilia A: a systematic review Haemophilia 2003 9 4 418 35 10.1046/j.1365-2516.2003.00780.x Open DOISearch in Google Scholar

11 Pinto P, Shelar T, Nawadkar V, et al. The epidemiology of FVIII inhibitors in Indian haemophilia A patients. Indian J Hematol Blood Transfus 2014; 30(4):356–63. doi: 10.1007/s12288-014-0342-z. PintoP ShelarT NawadkarV The epidemiology of FVIII inhibitors in Indian haemophilia A patients Indian J Hematol Blood Transfus 2014 30 4 356 63 10.1007/s12288-014-0342-z Open DOISearch in Google Scholar

12 Oldenburg J, Schröder J, Brackmann HH, Müller-Reible C, Schwaab R, Tuddenham E. Environmental and genetic factors influencing inhibitor development. Semin Hematol 2004; 41(1 Suppl 1); 82–8. doi: 10.1053/j.seminhematol.2003.11.016. OldenburgJ SchröderJ BrackmannHH Müller-ReibleC SchwaabR TuddenhamE Environmental and genetic factors influencing inhibitor development Semin Hematol 2004 41 1 Suppl 1 82 8 10.1053/j.seminhematol.2003.11.016 Open DOISearch in Google Scholar

13 Lorenzo JI, López A, Altisent C, Aznar JA. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age. Br J Haematol 2001; 113(3): 600–3. doi: 10.1046/j.1365-2141.2001.02828.x. LorenzoJI LópezA AltisentC AznarJA Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age Br J Haematol 2001 113 3 600 3 10.1046/j.1365-2141.2001.02828.x 11380444 Open DOISearch in Google Scholar

14 Witmer C, Young G. Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol 2013; 4(1): 59–72. doi: 10.1177/2040620712464509. WitmerC YoungG Factor VIII inhibitors in hemophilia A: rationale and latest evidence Ther Adv Hematol 2013 4 1 59 72 10.1177/2040620712464509 362976223610614 Open DOISearch in Google Scholar

15 Sachdeva A, Gunasekaran V, Ramya HN, et al. Consensus statement of the Indian Academy of Pediatrics in diagnosis and management of hemophilia. Indian Pediatr 2018; 55(7): 582–90. SachdevaA GunasekaranV RamyaHN Consensus statement of the Indian Academy of Pediatrics in diagnosis and management of hemophilia Indian Pediatr 2018 55 7 582 90 10.1007/s13312-018-1302-8 Search in Google Scholar

16 Radhakrishnan N, Shankar R, Maji M, Rana M. Initial experience of Emicizumab prophylaxis in children with inhibitor positive severe hemophilia A from a single center in India. Pediatr Hematol Oncol J 2021; 6(2): 97–99. doi: 10.1016/j.phoj.2021.03.0004. RadhakrishnanN ShankarR MajiM RanaM Initial experience of Emicizumab prophylaxis in children with inhibitor positive severe hemophilia A from a single center in India Pediatr Hematol Oncol J 2021 6 2 97 99 10.1016/j.phoj.2021.03.0004 Open DOISearch in Google Scholar

17 Ljung R, Auerswald G, Benson G, et al. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients. Eur J Haematol 2019; 102(2): 111–22. doi: 10.1111/ejh.13193. LjungR AuerswaldG BensonG Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients Eur J Haematol 2019 102 2 111 22 10.1111/ejh.13193 693622430411401 Open DOISearch in Google Scholar